The man who exposed a drug maker’s fraudulent marketing of an antipsychotic drug that is still given to Texas’s foster care children has won the Taxpayers Against Fraud Education Fund’s Whistleblower of the Year Award.
The fact that psychiatrists are prescribing antipsychotics to kids diagnosed “ADHD” is a clear example of the depths to which psychiatry will sink, putting normal kids at risk.
Johnson & Johnson, the company that makes the antipsychotic drug Risperdal, has tentatively agreed to a settlement of $2.2 billion to resolve a federal investigation into the company’s marketing practices.
I can’t think of a more fitting first guest for Mental Health Exposed. Our mission is to expose the fraud, abuse and incompetence in the mental health industry, as well as promote natural and effective methods of healing. Peter Breggin, MD and I discuss all of the above in the premier of Mental Health Exposed on Natural News Radio.
Peter R. Breggin, M.D. is a Harvard-trained psychiatrist and former full-time consultant with NIMH who is in private practice in Ithaca, New York. Dr. Breggin is the author of more than twenty books including the bestseller Talking Back to Prozac and the medical book Brain-Disabling Treatments in Psychiatry. His most recent book is Medication Madness, the Role of Psychiatric Drugs in Cases of Violence, Suicide and Crime. He is also the author of dozens of peer-reviewed scientific articles, many in the field of psychopharmacology.
Johnson & Johnson said on Thursday it will pay $158 million to settle a Texas lawsuit accusing the drugmaker of improperly marketing its Risperdal anti-psychotic drug to state residents on the Medicaid health program for the poor.
The settlement fully resolves all Risperdal-related claims in Texas, the company said. The agreement is specific to the state of Texas and does not involve other ongoing state or federal Risperdal litigation.